Literature DB >> 1310046

Reduction of the small subunit of Escherichia coli ribonucleotide reductase by hydrazines and hydroxylamines.

C Gerez1, M Fontecave.   

Abstract

Each polypeptide chain of protein R2, the small subunit of ribonucleotide reductase from Escherichia coli, contains a stable tyrosyl radical and an antiferromagnetically coupled diferric center. Recent crystallographic studies [Nordlund, P., Eklund, H., & Sjöberg, B.-M. (1990) Nature 345, 593-598] have shown that both the radical and the diiron site are deeply buried inside the protein and thus strongly support the hypothesis of long-range electron-transfer processes within protein R2. This study shows that monosubstituted hydrazines and hydroxylamines are able to reduce the tyrosyl radical and the ferric ions, under anaerobic conditions. It allows characterization of the site from which those compounds transfer their electrons to the iron/radical center. The efficiency of any given reducing agent is not solely governed by its redox potential but also by its size, its charge, and its hydrophobicity. We suggest, as a possible alternative to the long-range electron-transfer hypothesis, that conformational flexibility of the polypeptide chain might exist in solution and allow small molecules to penetrate the protein and react with the iron/radical center. This study also shows that two reduction mechanisms are possible, depending on which center, the radical or the metal, is reduced first. Full reduction of protein R2 yields reduced R2, characterized by a normal tyrosine residue and a diferrous center. Both the radical and the diferric center are regenerated from reduced R2 by reaction with oxygen, while only the diferric center is formed by reaction with hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310046     DOI: 10.1021/bi00118a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Redox-linked conformational control of proton-coupled electron transfer: Y122 in the ribonucleotide reductase β2 subunit.

Authors:  Adam R Offenbacher; Lori A Burns; C David Sherrill; Bridgette A Barry
Journal:  J Phys Chem B       Date:  2013-07-03       Impact factor: 2.991

Review 2.  Role of metal dyshomeostasis in Alzheimer's disease.

Authors:  David J Bonda; Hyoung-gon Lee; Jeffrey A Blair; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Metallomics       Date:  2011-02-07       Impact factor: 4.526

3.  Two distinct mechanisms of inactivation of the class Ic ribonucleotide reductase from Chlamydia trachomatis by hydroxyurea: implications for the protein gating of intersubunit electron transfer.

Authors:  Wei Jiang; Jiajia Xie; Paul T Varano; Carsten Krebs; J Martin Bollinger
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

Review 4.  Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!

Authors:  David J Bonda; Gang Liu; Ping Men; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-02       Impact factor: 4.388

5.  Redox-linked changes to the hydrogen-bonding network of ribonucleotide reductase β2.

Authors:  Adam R Offenbacher; Ellen C Minnihan; JoAnne Stubbe; Bridgette A Barry
Journal:  J Am Chem Soc       Date:  2013-04-17       Impact factor: 15.419

6.  Escherichia coli and herpes-simplex-virus ribonucleotide reductase R2 subunit. Compared reactivities of the redox centres.

Authors:  M Atta; N Lamarche; J P Battioni; B Massie; Y Langelier; D Mansuy; M Fontecave
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  An active dimanganese(III)-tyrosyl radical cofactor in Escherichia coli class Ib ribonucleotide reductase.

Authors:  Joseph A Cotruvo; Joanne Stubbe
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

8.  Methyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzyme.

Authors:  Esther Julián; Aida Baelo; Joan Gavaldà; Eduard Torrents
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.